University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 13 of 14
Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis
NCT00583973
Computer Modeling With Reconstruction of Maxillofacial Skeleton
NCT00583856
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784
Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
NCT00364819
Coaching to Improve Care of Cancer Pain
NCT00283166
Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART
NCT00386971
Molecular and Cellular Characterization of Spongiotic Dermatitis
NCT00371163
Community-based Hepatitis B Interventions for Hmong Adults
NCT00888407
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
NCT00897962
Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds
NCT00616707
Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
NCT00408499
Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques
NCT00755300
Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux
NCT00584259
The Effects of Walnuts, Walnut-Oil, Almonds and Fish Oils on Glucose Homeostasis in Polycystic Ovary Syndrome
NCT00579904
Gene Expression Profiles in Multiple Sclerosis (MS)
NCT00704834
Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement
NCT00584116
Metabolism of the Insecticide Permethrin
NCT00572884
The Role of Leptin Receptors in NASH
NCT00583999
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
NCT00389922
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
NCT00628654
National Cooperative Growth Study in CKD
NCT00616278
Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes
NCT00879515
Effects of SAMe in Patients With Alcoholic Liver Disease
NCT00573313
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
NCT00221299
Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon Cancer
NCT00273585
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers
NCT00368693
Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks
NCT01165853
Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks
NCT00367042
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
NCT00864396
Beta Blocker for Chronic Wound Healing
NCT00368602
Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery
NCT00710437
To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
NCT00367328
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
NCT00389805
Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
NCT00387322
Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
NCT00388089
Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00376727
Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma
NCT00280683
Evaluation of Breast CT
NCT00584233
The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins
NCT00366964
Effects of Probiotic and Prebiotic Combinations on Premature Infants
NCT00282113
Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.
NCT00263107
Use of Robotics for Cholecystectomy; Retrospective Review of Outcomes, Set Up and Learning Curves
NCT03059745
Effects of GCP on Prostate Cancer.
NCT00269555
Cannabis for Spasticity in Multiple Sclerosis
NCT00682929
Use of Robotic Telerounding After Operative Procedures
NCT00261157
Radiofrequency Ablation of Uterine Fibroids
NCT00584207
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
NCT00367016
Ultrasound Assisted Peripheral Venous Access in Young Children
NCT00557154
Lido Workset Study
NCT00710645
Neurohumoral Control of Intestinal Electrical and Mechanical Activity
NCT00852553
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.